4 studies found for: weill | Open Studies | "Colitis, Ulcerative"
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
A Study of LY3074828 in Participants With Moderate to Severe Ulcerative Colitis
A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
† Study has passed its completion date and status has not been verified in more than two years.